Walana

Company Overview

Snapshot

Founded in March 2015 by Markus Glimm and Gil Gat, Walana operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its healthcare chatbot technology.

Business overview

Walana is a Health Tech & Life Sciences company that aims to transform patient interactions with pharmaceutical companies and healthcare providers through specialized healthcare chatbots combined with human communication. Its core product, ViTUS, is a chatbot designed to collect and analyze wellness and symptom data, identify patterns, and create personalized plans for patients. ViTUS also provides real-time data to physicians, enabling more tailored treatments. Walana serves patients, pharmaceutical companies, and healthcare providers, leveraging artificial intelligence and big data analytics to enhance decision-making in digital healthcare.

Company Intelligence Q&A

What is Walana's primary focus?

Walana focuses on developing healthcare chatbots to improve patient engagement and health management, facilitating better interactions between patients, pharmaceutical companies, and healthcare providers.

What is the name of Walana's key product?

Walana's key product is ViTUS, a chatbot that collects and analyzes wellness and symptom-related data to create personalized health plans and provide real-time data to physicians.

When was Walana founded?

Walana was founded in March 2015 by Markus Glimm and Gil Gat.

What markets does Walana target with its products?

Walana targets markets including China, South Korea, Japan, and Singapore with its healthcare chatbot solutions.

What technology underpins Walana's offerings?

Walana leverages artificial intelligence and data analytics, specifically through chatbots, to process millions of data points for enhanced decision-making in healthcare.